Zhejiang Hisun Pharmaceutical Hits Day High with Strong 3.75% Intraday Surge

Zhejiang Hisun Pharmaceutical Co., Ltd. has shown significant activity today, with the stock rising by 3.75% as of March 27, 2026. The stock reached an intraday high of CNY 10.27, reflecting a positive movement in the market. In terms of performance metrics, Zhejiang Hisun has outperformed the China Shanghai Composite index in the one-day performance, which recorded a modest increase of 0.63%. However, over the past week, the stock has seen a slight decline of 0.68%, contrasting with the index's drop of 1.09%. Looking at longer-term trends, the stock has delivered a solid return of 15.84% over the past year, closely aligning with the index's performance of 16.01%. Year-to-date, Zhejiang Hisun has also shown resilience with a gain of 3.54%, while the broader index has faced a decline of 1.39%. With a market capitalization of CNY 11,262 million, Zhejiang Hisun operates within the Pharmaceuticals & Biotechnology sector, showcasing a price-to-earnings ratio of 25.00 and a dividend yield of 2.25%. These metrics highlight the company's position in the market and its financial health.